Quick Answer
CHINA PHARMA HOLDINGS, INC. reported Net Income of -$4.74 million for fiscal year 2024.
CHINA PHARMA HOLDINGS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$4.74M | -53.8% |
| 2023 | -$3.08M | +22.5% |
| 2022 | -$3.97M | -16.9% |
| 2021 | -$3.40M | -18.6% |
| 2020 | -$2.87M | +86.2% |
| 2019 | -$20.70M | -92.6% |
| 2018 | -$10.75M | +44.2% |
| 2017 | -$19.28M | -109.9% |
| 2016 | -$9.18M | +40.4% |
| 2015 | -$15.41M | +61.0% |
| 2014 | -$39.55M | -97.7% |
| 2013 | -$20.01M | -533.3% |
| 2012 | $4.62M | -76.0% |
| 2011 | $19.27M | -17.7% |
| 2010 | $23.41M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$651.5K | +41.7% | -23.3% |
| June 30, 2025 | -$528.4K | +63.3% | +32.7% |
| March 31, 2025 | -$785.6K | +17.8% | +29.7% |
| September 30, 2024 | -$1.12M | -43.8% | +22.3% |
| June 30, 2024 | -$1.44M | -142.5% | -50.4% |
| March 31, 2024 | -$955.9K | -100.8% | -22.9% |
| September 30, 2023 | -$777.6K | +1.7% | -31.1% |
| June 30, 2023 | -$593.0K | +33.2% | -24.6% |
- CHINA PHARMA HOLDINGS, INC. showed a decrease of -53.8% in Net Income compared to the prior fiscal year.
- Over the 2010–2024 period, CHINA PHARMA HOLDINGS, INC.’s net income has declined by 120.2% (from $23.41 million to -$4.74 million).
- The most recent figure is from CHINA PHARMA HOLDINGS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: